Aquestive Therapeutics, Inc. Contracts & Agreements
81 Contracts & Agreements
- Business Finance (33 contracts)
- Business Operations (8)
- Human Resources (23)
- Intellectual Property (5)
- Real Estate (1)
- Uncategorized (11)
- Underwriting Agreement, dated March 19, 2024, by and among Aquestive Therapeutics, Inc. and Leerink Partners LLC and Piper Sandler & Co., as representatives of the several... (Filed With SEC on March 21, 2024)
- Executive Employment Agreement between the Company and Daniel Barber, effective on July 15, 2022 (Filed With SEC on August 2, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on June 8, 2022)
- Placement Agency Agreement dated June 6, 2022, between Aquestive Therapeutics, Inc. and A.G.P./Alliance Global Partners (Filed With SEC on June 8, 2022)
- Form of Common Stock Warrant (Filed With SEC on June 8, 2022)
- Form of Securities Purchase Agreement dated June 6, 2022, by and among Aquestive Therapeutics, Inc. and the purchasers (Filed With SEC on June 8, 2022)
- Amendment No. 2 to the Purchase Agreement, dated as of May 13, 2022, by and among the Aquestive Therapeutics, Inc. and the Purchasers signatory thereto (Filed With SEC on May 17, 2022)
- Fifth Supplemental Indenture, dated May 13, 2022, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank Trust Company, National... (Filed With SEC on May 17, 2022)
- Separation Agreement, dated May 17, 2022, between Aquestive Therapeutics, Inc. and Keith J. Kendall (Filed With SEC on May 17, 2022)
- License, Development and Supply Agreement, dated as of March 2022, by and between Aquestive Therapeutics, Inc. and Haisco Pharmaceutical Group Co., Ltd (Filed With SEC on May 4, 2022)
- Registration Rights Agreement, dated as of April 12, 2022, by and between the Company and Lincoln Park (Filed With SEC on April 13, 2022)
- Purchase Agreement, dated as of April 12, 2022, by and between the Company and Lincoln Park (Filed With SEC on April 13, 2022)
- First Amendment to Executive Employment Agreement, dated as of June 30, 2021, by and between Aquestive Therapeutics, Inc. and Keith J. Kendall (Filed With SEC on March 8, 2022)
- First Amendment to Executive Employment Agreement, dated as of June 30, 2021, by and between Aquestive Therapeutics, Inc. and Alexander Mark Schobel (Filed With SEC on March 8, 2022)
- Consent Fee Letter, dated October 7, 2021, among Aquestive Therapeutics, Inc. and the Noteholder parties thereto (Filed With SEC on October 8, 2021)
- Fourth Supplemental Indenture, dated October 7, 2021, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank, National Association,... (Filed With SEC on October 8, 2021)
- Waiver Agreement dated as of September 30, 2021, among Aquestive Therapeutics, Inc., at the Noteholder party thereto (Filed With SEC on October 6, 2021)
- Third Supplemental Indenture, dated August 6, 2021, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank, National Association, as... (Filed With SEC on August 9, 2021)
- Letter Agreement between the Company and A. Ernest Toth, Jr. , effective on June 15, 2021 (Filed With SEC on August 3, 2021)
- Third Amendment to License Agreement by and between Aquestive Therapeutics, Inc. and Sunovion Pharmaceuticals Inc. (formerly, Cynapsus Therapeutics, Inc.) (Filed With SEC on July 30, 2021)
- Amendment No. 1 to the Equity Distribution Agreement, dated March 26, 2021, by and between Aquestive Therapeutics, Inc. and Piper Sandler & Co (Filed With SEC on March 26, 2021)
- Second Supplemental Indenture dated November 20, 2020, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank National Association,... (Filed With SEC on March 9, 2021)
- Purchase and Sale Agreement, dated as of November 3, 2020, by and between Aquestive Therapeutics, Inc. and MAM Pangolin Royalty, LLC (Filed With SEC on March 9, 2021)
- Second Amendment to License Agreement, by and between Aquestive Therapeutics, Inc. and Sunovion Pharmaceuticals, Inc., dated as of October 23, 2020 (Filed With SEC on March 9, 2021)
- Separation Agreement, dated as of December 16, 2020, by and between Aquestive Therapeutics, Inc. and John T. Maxwell (Filed With SEC on March 9, 2021)
- Form of 2020 Purchase Agreement in connection with the 2020 issuance of 12.5% Senior Secured Notes (Filed With SEC on March 9, 2021)
- First Supplemental Indenture dated November 3, 2020, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank National Association, as... (Filed With SEC on March 9, 2021)
- Paycheck Protection Program Promissory Note dated April 17, 2020, between Aquestive Therapeutics, Inc., as Borrower, and Frost Bank, as Lender (Filed With SEC on April 20, 2020)
- First Amendment to License Agreement, effective as of March 16, 2020, by and between Aquestive Therapeutics, Inc. and Sunovion Pharmaceuticals Inc. (formerly, Cynapsus... (Filed With SEC on March 20, 2020)
- Aquestive Therapeutics, Inc. Employee Stock Purchase Plan as Amended (Filed With SEC on March 11, 2020)
- Description of Securities Registered under Section 12 of the Exchange Act (Filed With SEC on March 11, 2020)
- Underwriting Agreement, dated December 12, 2019, by and between Aquestive Therapeutics, Inc. and BMO Capital Markets Corp., as representative of the several underwriters named... (Filed With SEC on December 16, 2019)
- Form of Warrant (Filed With SEC on July 16, 2019)
- Collateral Agreement dated as of July 15, 2019 among Aquestive Therapeutics, Inc., as Issuer, the Other Grantors from time to time party thereto, U.S. Bank National Association,... (Filed With SEC on July 16, 2019)
- Form of Purchase Agreement (Filed With SEC on July 16, 2019)
- Indenture Dated as of July 15, 2019, among Aquestive Therapeutics, Inc., as Issuer, any Guarantor that becomes party thereto and U.S. Bank National Association, as Trustee and... (Filed With SEC on July 16, 2019)
- Aquestive Therapeutics, Inc. Employee Stock Purchase Plan (Filed With SEC on June 18, 2019)
- Employment Agreement dated September 10, 2018, by and between Aquestive Therapeutics, Inc., LLC and Lori J. Braender (Filed With SEC on November 6, 2018)
- Employment Agreement dated June 30, 2018, by and between Aquestive Therapeutics, Inc., LLC and Keith J. Kendall (Filed With SEC on July 16, 2018)
- Employment Agreement dated July 9, 2018, by and between Aquestive Therapeutics, Inc., LLC and A. Mark Schobel (Filed With SEC on July 16, 2018)
- Form of Underwriting Agreement (Filed With SEC on July 16, 2018)
- Form of Common Stock Certificate of the Registrant (Filed With SEC on June 27, 2018)
- Form of Stock Option Agreement dated April 2018 (Filed With SEC on June 27, 2018)
- Industrial Lease Agreement by and between Ashland Northwest Partners, L.P. and MonoSol Rx, LLC, dated October 24, 2006 (as amended on October 24, 2011 and February 8, 2018) (Filed With SEC on June 27, 2018)
- License Agreement by and between MonoSol Rx, LLC and Cynapsus Therapeutics Inc., dated as of April 1, 2016 (Filed With SEC on June 27, 2018)
- Agreement to Terminate CLA by and between MonoSol Rx, LLC and KemPharm, Inc., dated as of March 20, 2012 (Filed With SEC on June 27, 2018)
- Agreement by and between MonoSol Rx, LLC and Indivior UK Limited, dated September 24, 2017 (Filed With SEC on June 27, 2018)
- Commercial Exploitation Agreement by and between MonoSol Rx, LLC and Reckitt Benckiser Pharmaceuticals Inc., dated August 15, 2008 (as amended on August 19, 2009, November 13,... (Filed With SEC on June 27, 2018)
- Employment Agreement dated June 26, 2018, by and between Aquestive Therapeutics, Inc., LLC and Daniel Barber (Filed With SEC on June 27, 2018)
- Warrant to Purchase 11,625,437 senior common equity interests to Perceptive Credit Holdings, LP, dated as of January 1, 2018 (Filed With SEC on June 27, 2018)
- Registration Rights Agreement, dated June 24, 2016, by and between Aquestive Partners, LLC and certain of the holders of its membership interests (Filed With SEC on June 27, 2018)
- Form of Indemnity Agreement by and between Registrant and its directors and officers (Filed With SEC on June 27, 2018)
- Omnibus Amendment No. 1 dated January 1, 2018, by and between Monosol Rx, LLC, the Lenders party thereto and Perceptive Credit Holdings, LP (Filed With SEC on June 27, 2018)
- Employment Agreement dated June 26, 2018, by and between Aquestive Therapeutics, Inc., LLC and John T. Maxwell (Filed With SEC on June 27, 2018)
- Credit Agreement and Guaranty dated August 16, 2016, by and between Monosol Rx, LLC and Perceptive Credit Opportunities Fund, LP (Filed With SEC on June 27, 2018)
- Amendment No. 2 to Credit Agreement and Guaranty dated May 21, 2018, by and between Aquestive Therapeutics, Inc. and Perceptive Credit Opportunities Fund, LP (Filed With SEC on June 27, 2018)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 29, 2007)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 29, 2007)
- MONOSOL RX LLC AMENDED AND RESTATED PERFORMANCE UNIT APPRECIATION PLAN (Filed With SEC on August 29, 2007)
- MONOSOL Rx, INC. RESTRICTED STOCK AGREEMENT (Filed With SEC on August 29, 2007)
- STOCKOPTION AGREEMENT UNDER THE MONOSOL Rx, INC. 2007 STOCK INCENTIVE PLAN (Filed With SEC on August 29, 2007)
- MONOSOL RX, INC. 2007 STOCK INCENTIVE PLAN (Filed With SEC on August 29, 2007)
- SEPARATIONAGREEMENT AND GENERAL RELEASE (Filed With SEC on July 25, 2007)
- INDEMNIFICATION AGREEMENT (Filed With SEC on July 25, 2007)
- Commercial Supply Agreement (Filed With SEC on May 14, 2007)
- MONOSOL RX, LLC AMENDED AND RESTATED PERFORMANCE UNITS PLAN B Amended and Restated EffectiveSeptember 18, 2006 (Filed With SEC on May 14, 2007)
- MONOSOL RX, LLC AMENDED AND RESTATED PERFORMANCE UNITS PLAN Amendedand Restated Effective September 18, 2006 (Filed With SEC on May 14, 2007)
- Summaryof Director Compensation (Filed With SEC on May 14, 2007)
- DEVELOPMENTAND SUPPLY AGREEMENT (Filed With SEC on May 14, 2007)
- BENZYDAMINE DEVELOPMENT AGREEMENT (Filed With SEC on May 14, 2007)
- SUPPLY AGREEMENT (Filed With SEC on May 14, 2007)
- AGREEMENT by and between Medtech Products inc. and MonoSolRx LLC (Filed With SEC on May 14, 2007)
- EXCLUSIVESTRATEGIC SUPPLY AGREEMENT By and Between PHILIP MORRIS USA INC. And MONOSOL RX, LLC [*] Effective February 8, 2007 (Filed With SEC on May 14, 2007)
- LICENSEAGREEMENT (Filed With SEC on May 14, 2007)
- DEVELOPMENT AGREEMENT (Filed With SEC on May 14, 2007)
- SUPPLYAGREEMENT (Filed With SEC on May 14, 2007)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 14, 2007)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 14, 2007)
- AMENDED AND RESTATED EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 14, 2007)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 14, 2007)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 14, 2007)